首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis.
【24h】

Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis.

机译:N0期头颈部皮肤鳞状细胞癌的颈淋巴结和腮腺淋巴结的选择性管理:决策分析。

获取原文
获取原文并翻译 | 示例
           

摘要

There is uncertainty regarding the threshold for recommending elective regional nodal treatment in the management of stage N0 cutaneous squamous cell carcinoma of the head and neck (cSCCHN). Elective treatment in the form of nodal surgery or irradiation is associated with morbidity. However, patients managed with careful observation sometimes present with advanced disease which often require more extensive therapy or may be unsalvageable altogether. We used decision analysis to examine the tradeoffs and benefits of different management approaches in the stage N0 patient. A decision tree comprising the three different treatment strategies was built: surveillance, elective nodal dissection (END) and elective nodal irradiation (ENI). Probabilities of nodal recurrence and likelihood of successful salvage were obtained from the literature. A convenience sample of patients previously treated for metastatic and non-metastatic cSCCHN was interviewed using the standard gamble technique to determine utility for post-treatment health states. Sensitivity analysis was performed and the effect on the expected utility was examined. When the probability of occult metastasis was >19 %, ENI resulted in a higher expected utility than observation. When the probability of occult metastasis exceeds 25 %, END has a higher expected utility compared to observation. Given the current available evidence, a wait-and-see approach is justified in patients with a probability of occult metastases <19 %.
机译:关于在头颈部N0期皮肤鳞状细胞癌(cSCCHN)的治疗中推荐选择性区域淋巴结治疗的阈值尚不确定。结节手术或放射形式的选择性治疗与发病率有关。但是,经过仔细观察处理的患者有时会出现晚期疾病,这些疾病通常需要更广泛的治疗或完全无法挽救。我们使用决策分析来检查N0期患者不同管理方法的权衡和收益。建立了包括三种不同治疗策略的决策树:监视,选择性淋巴结清扫(END)和选择性淋巴结照射(ENI)。淋巴结复发的概率和成功挽救的可能性从文献中获得。使用标准赌博技术对先前接受过转移和非转移性cSCCHN治疗的患者的便利性样本进行了访谈,以确定其对治疗后健康状况的实用性。进行敏感性分析,并检查对预期效用的影响。当隐匿转移的可能性> 19%时,ENI产生的预期效用高于观察值。当隐匿转移的可能性超过25%时,与观察相比,END具有更高的预期效用。鉴于目前可获得的证据,对于隐匿性转移率小于19%的患者,应采取观望态度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号